Compared with long-acting insulin, GLP-1RA therapy reduces the risk of composite liver disease (cirrhosis or hepatocellular carcinoma) in patients with type 2 diabetes by 44%, with a 41% reduction in cirrhosis risk and a 53% reduction in hepatocellular carcinoma risk
doi:10.1016/S2213-8587(15)00414-2 (link) [3] : Pratley R, Amod A, Hoff ST, et al
Gastrointestinal Side Effects GLP-1 receptor agonists commonly cause GI side effects nausea, bloating, reflux/heartburn, constipation, and sometimes vomiting
Behavioural therapy means having access to a specialist who can help with understanding obesity, how the medications work, as well as sleep and nutrition plans
Orangetheorys workouts include heart rate-based zone training on the treadmill and rowers, designed to boost cardiovascular health while tracking member heart rates